Cover Image
市場調查報告書

肝功能障礙:全球臨床實驗檢討

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 239408
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
肝功能障礙:全球臨床實驗檢討 Hepatic Insufficiency Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月27日 內容資訊: 英文 75 Pages
簡介

本報告提供肝功能障礙相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7·E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,並彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 肝功能障礙
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:肝功能障礙臨床實驗數量上消化管疾病臨床實驗數量所佔比例

Phase別臨床實驗數量:G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:肝功能障礙臨床實驗數量上消化管疾病臨床實驗數量所佔比例

Phase別臨床實驗數量:E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗 肝功能障礙

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗的主要參與企業 - 肝功能障礙治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Merck & Co., Inc.
    • Novartis AG
    • Eli Lilly and Company
    • Puma Biotechnology, Inc.
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • C. H. Boehringer Sohn AG & Co. KG
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Astellas Pharma 歐洲 Ltd.
  • 有代表性的研究機關/醫院臨床實驗概要
    • Copenhagen University Hospital Gentofte
    • National Cancer Institute
    • Aarhus University
    • Donau-Universitat Krems
    • Huashan Hospital
    • Mayo Clinic
    • McGill University Health Center

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2642CTIDB

GlobalData's clinical trial report, "Hepatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hepatic Insufficiency
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hepatic Insufficiency
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hepatic Insufficiency Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Puma Biotechnology, Inc.
      • Clinical Trial Overview of Puma Biotechnology, Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Astellas Pharma Europe Ltd.
      • Clinical Trial Overview of Astellas Pharma Europe Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • Copenhagen University Hospital Gentofte
      • Clinical Trial Overview of Copenhagen University Hospital Gentofte
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Aarhus University
      • Clinical Trial Overview of Aarhus University
      • Donau-Universitat Krems
      • Clinical Trial Overview of Donau-Universitat Krems
      • Huashan Hospital
      • Clinical Trial Overview of Huashan Hospital
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • McGill University Health Center
      • Clinical Trial Overview of McGill University Health Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Puma Biotechnology, Inc., 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Europe Ltd., 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital Gentofte, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Donau-Universitat Krems, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015*

List of Figures

  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top